MPH Health Care AG

MPH Health Care AG operates in the healthcare market in Germany. It produces medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products, including botulinum toxin, hyaluronic acid, implants, and provides services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic admixture and concomitant medications; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG. MPH Health Care AG was founded in 2008 and is based in Berlin, Germany.